Literature DB >> 30302719

Adipocyte proteome and secretome influence inflammatory and hormone pathways in glioma.

J Almeida1,2, J Costa1, P Coelho1,3, V Cea4, M Galesio5, J P Noronha5, M S Diniz5, C Prudêncio1,2, R Soares3,6, C Sala4, Rúben Fernandes7,8.   

Abstract

Gliomas represent the most common primary malignant brain tumors in adults, with an extremely poor prognosis. Among several risk factors, lifestyle was also recently identified as a major risk factor for the development of primary glioma. In the present study, we explore the relationship between obesity and glioma in a cellular model. Thus, we have study the influence of adipocytes secretome on glioma cell line GL261. Using the 3T3-L1 adipocyte cell line, and its conditioned medium (adipokines-enriched medium), we showed that adipocyte-released factors relate with glioma angiogenic, growth, hormones and metabolic behavior by MALDI-TOF-MS and proteomic array analysis. In a first view, STI1, hnRNPs and PGK1 are under expressed on CGl. Similarly, both carbonic anhydrase and aldose reductase are even suppressed in glioma cells that grown under adipokines-enriched environment. Contrariwise, RFC1, KIF5C, ANXA2, N-RAP and RACK1 are overexpressed in GL261 cell the in the presence of the adipokines-enriched medium. We further identified the factors that are released by adipocyte cells, and revealed that several pro-inflammatory and angiogenic factors, such as IL-6, IL-11, LIF, PAI-1, TNF-α, endocan, HGF, VEGF IGF-I, were secreted to the medium into a high extent, whereas TIMP-1 and SerpinE1 were under expressed on CGl. This study discloses an interesting in vitro model for the study of glioma biology under a "obesity" environment, that can be explored for the understanding of cancer cells biology, for the search of biomarkers, prognostic markers and therapeutic approaches.

Entities:  

Keywords:  Adipo-proteomics; GL261; Glioma; Obesity

Mesh:

Substances:

Year:  2018        PMID: 30302719     DOI: 10.1007/s11011-018-0327-y

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  54 in total

Review 1.  Angiogenesis in health and disease.

Authors:  Peter Carmeliet
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 2.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

Review 3.  Obesity and cancer phenotype: Is angiogenesis a missed link?

Authors:  Fernando Mendonça; Raquel Soares
Journal:  Life Sci       Date:  2015-08-19       Impact factor: 5.037

4.  Endocan, a new invasion and angiogenesis marker of pituitary adenomas.

Authors:  Fumihiro Matano; Daizo Yoshida; Yudo Ishii; Shigeyuki Tahara; Akira Teramoto; Akio Morita
Journal:  J Neurooncol       Date:  2014-02-07       Impact factor: 4.130

5.  Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.

Authors:  Anwar Hossain; Joy Gumin; Feng Gao; Javier Figueroa; Naoki Shinojima; Tatsuya Takezaki; Waldemar Priebe; Diana Villarreal; Seok-Gu Kang; Celine Joyce; Erik Sulman; Qianghu Wang; Frank C Marini; Michael Andreeff; Howard Colman; Frederick F Lang
Journal:  Stem Cells       Date:  2015-05-27       Impact factor: 6.277

6.  The role of annexin A2 in tumorigenesis and cancer progression.

Authors:  Noor A Lokman; Miranda P Ween; Martin K Oehler; Carmela Ricciardelli
Journal:  Cancer Microenviron       Date:  2011-03-05

7.  Annexin A2 promotes glioma cell invasion and tumor progression.

Authors:  Haiyan Zhai; Suchitra Acharya; Iordanis Gravanis; Saira Mehmood; Roberta J Seidman; Kenneth R Shroyer; Katherine A Hajjar; Stella E Tsirka
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

8.  Anti-angiogenic therapy induces integrin-linked kinase 1 up-regulation in a mouse model of glioblastoma.

Authors:  Chiara Verpelli; Giulio Bertani; Valentina Cea; Monica Patti; Andreas Bikfalvi; Lorenzo Bello; Carlo Sala
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

9.  The association of annexin A2 and cancers.

Authors:  Xiaohui Zhang; Shuqing Liu; Chunmei Guo; Junwei Zong; Ming-Zhong Sun
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

10.  Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.

Authors:  Maryse Delehedde; Lucie Devenyns; Claude-Alain Maurage; Romain R Vivès
Journal:  Int J Cell Biol       Date:  2013-03-28
View more
  6 in total

1.  Tumor-associated macrophages based signaling pathway analysis and hub genes identification in glioma.

Authors:  Xiang Wang; Weihai Ning; Zhiqiang Qiu; Shenglun Li; Hongwei Zhang; Chunjiang Yu
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

Review 2.  Putting Proteomics Into Immunotherapy for Glioblastoma.

Authors:  Liangyu Chen; Di Qin; Xinyu Guo; Qixue Wang; Jie Li
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561

3.  Body mass index and glioma risk: A prospective multicenter study.

Authors:  Chuan Shao; Hui Tang; Xiaoya Wang; Jiaquan He; Pan Wang; Nan Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-29       Impact factor: 6.055

4.  Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.

Authors:  Ziye Yu; Huan Yang; Kun Song; Pengfei Fu; Jingjing Shen; Ming Xu; Hongzhi Xu
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

5.  ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.

Authors:  Houshi Xu; Anke Zhang; Xiaying Han; Yanning Li; Zeyu Zhang; Liying Song; Wei Wang; Meiqing Lou
Journal:  Cancer Immunol Immunother       Date:  2021-07-27       Impact factor: 6.968

Review 6.  The Adipose Tissue at the Crosstalk Between EDCs and Cancer Development.

Authors:  Emma Bokobza; Charlotte Hinault; Victor Tiroille; Stéphan Clavel; Frédéric Bost; Nicolas Chevalier
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-20       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.